Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization
Journal of Pathology and Translational Medicine. 2020;54(6):480-488 
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
Infectious Agents and Cancer. 2020;15(1):
In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix
Pathology. 1991;23(2):85-89
p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection
Histopathology. 2010;57(3):342-350
RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization
Oral Oncology. 2016;55:11-16
Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
Acta Medica Bulgarica. 2017;44(2):14-19
HPV RNA in situ Hybridization in HPV-Related Head and Neck Squamous Cell Carcinoma: An Improvement over HPV DNA in situ Hybridization
Journal of the American Society of Cytopathology. 2018;7(5):S12-S13
Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous-cell carcinomas byin situ hybridization
International Journal of Cancer. 1993;55(1):171-173
Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV‐related head and neck squamous cell carcinoma
Cancer Cytopathology. 2019;127(10):632-642
Human Papillomavirus (HPV) and HPV Vaccines
Encyclopedia of Adolescence. 2018;1804-1806